CRYOPORT, INC. Property, Plant and Equipment, Gross
CRYOPORT, INC. (CYRX) had Property, Plant and Equipment, Gross of $134.93 million as of 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-03-05
- 2025-12-31: Property, Plant and Equipment, Gross $134.93M.
- 2024-12-31: Property, Plant and Equipment, Gross $117.79M; Property, Plant and Equipment, Gross as first filed $134.70M.
- 2023-12-31: Property, Plant and Equipment, Gross $121.44M.
- 2022-12-31: Property, Plant and Equipment, Gross $90.94M.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2025-12-31 | $134.93M 10-K · filed 2026-03-05 | |
| 2024-12-31 | $117.79M 10-K · filed 2026-03-05 | $134.70M 10-K · filed 2025-03-07 |
| 2023-12-31 | $121.44M 10-K · filed 2025-03-07 | |
| 2022-12-31 | $90.94M 10-K · filed 2024-03-13 | |
| 2021-12-31 | $69.03M 10-K · filed 2023-02-28 | |
| 2020-12-31 | $45.55M 10-K · filed 2022-02-28 | |
| 2019-12-31 | $15.43M 10-K · filed 2021-03-01 | $15.97M 10-K · filed 2020-03-10 |
| 2018-12-31 | $6.98M 10-K · filed 2020-03-10 | |
| 2017-12-31 | $4.60M 10-K · filed 2019-03-13 | $4.06M 10-K · filed 2018-03-08 |
| 2016-12-31 | $2.90M 10-K · filed 2018-03-08 | |
| 2016-03-31 | $2.54M 10-KT · filed 2017-03-13 | |
| 2015-03-31 | $1.44M 10-K · filed 2016-06-28 | |
| 2014-03-31 | $1.49M 10-K · filed 2015-05-19 | |
| 2013-03-31 | $1.40M 10-K · filed 2014-06-25 | |
| 2012-03-31 | $1.32M 10-K · filed 2013-06-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |